Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective.WHAT IS KNOWN AND OBJECTIVE

ENSEMBLE
Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective.WHAT IS KNOWN AND OBJECTIVE

ENSEMBLE
Since WHO declared the pandemic of COVID-19, vaccines have been developed to fight against this infectious disease. 
WHO
The UCM IDS team performs responsibilities in both clinical and mobile unit settings, the IDS team is able to facilitate and expand the enrolment to the minority population in underserved communities.
UCM IDS